References
- PalmerECGilleenJDavidASThe relationship between cognitive insight and depression in psychosis and schizophrenia: a review and meta-analysisSchizophr Res20151661–326126826095015
- KitchenHRofailDHeronLSaccoPCognitive impairment associated with schizophrenia: a review of the humanistic burdenAdv Ther201229214816222351433
- BortolatoBMiskowiakKWKohlerCAVietaECarvalhoAFCognitive dysfunction in bipolar disorder and schizophrenia: a systematic review of meta-analysesNeuropsychiatr Dis Treat2015113111312526719696
- BarchDMCeaserACognition in schizophrenia: core psychological and neural mechanismsTrends Cogn Sci2012161273422169777
- HoeMNakagamiEGreenMFBrekkeJSThe causal relationships between neurocognition, social cognition and functional outcome over time in schizophrenia: a latent difference score approachPsychol Med201242112287229922475159
- KalksteinSHurfordIGurRCNeurocognition in schizophreniaCurr Top Behav Neurosci2010437339021312407
- SchaeferJGiangrandeEWeinbergerDRDickinsonDThe global cognitive impairment in schizophrenia: consistent over decades and around the worldSchizophr Res20131501425023911259
- KeefeRSHarveyPDCognitive impairment in schizophreniaHandb Exp Pharmacol20122131137
- LinCYTsaiGELaneHYAssessing and treating cognitive impairment in schizophrenia: current and futureCurr Pharm Des201420325127513824410565
- BakkourNSampJAkhrasKSystematic review of appropriate cognitive assessment instruments used in clinical trials of schizophrenia, major depressive disorder and bipolar disorderPsychiatry Res2014216329130224656516
- BuchananRWDavisMGoffDA summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophreniaSchizophr Bull200531151915888422
- KeefeRSFoxKHHarveyPDCucchiaroJSiuCLoebelACharacteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trialSchizophr Res20111252–316116821075600
- KeefeRSHarveyPDGoldbergTENorms and standardization of the Brief Assessment of Cognition in Schizophrenia (BACS)Schizophr Res20081021–310811518495435
- KeefeRSPoeMWalkerTMHarveyPDThe relationship of the Brief Assessment of Cognition in Schizophrenia (BACS) to functional capacity and real-world functional outcomeJ Clin Exp Neuropsychol200628226026916484097
- KeefeRSPoeMWalkerTMKangJWHarveyPDThe Schizophrenia Cognition Rating Scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacityAm J Psychiatry2006163342643216513863
- KeefeRSGoldbergTEHarveyPDGoldJMPoeMPCoughenourLThe Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive batterySchizophr Res2004682–328329715099610
- KanedaYSumiyoshiTKeefeRIshimotoYNumataSOhmoriTBrief assessment of cognition in schizophrenia: validation of the Japanese versionPsychiatry Clin Neurosci200761660260918081619
- BraletMCFalissardBNeveuXLucas-RossMEskenaziAMKeefeRSValidation of the French version of the BACS (the brief assessment of cognition in schizophrenia) among 50 French schizophrenic patientsEur Psychiatry200722636537017434715
- AnselmettiSPolettiSErmoliEThe Brief Assessment of Cognition in Schizophrenia. Normative data for the Italian populationNeurol Sci2008292859218483705
- SegarraNBernardoMGutierrezFSpanish validation of the Brief Assessment in Cognition in Schizophrenia (BACS) in patients with schizophrenia and healthy controlsEur Psychiatry2011262697320435446
- SachsGWinklbaurBJagschRKeefeRSValidation of the German version of the Brief Assessment of Cognition in Schizophrenia (BACS) – preliminary resultsEur Psychiatry2011262747720427153
- MazhariSParvareshNEslami ShahrbabakiMSadeghiMMNakhaeeNKeefeRSValidation of the Persian version of the Brief Assessment Of Cognition in Schizophrenia in patients with schizophrenia and healthy controlsPsychiatry Clin Neurosci201468216016624552637
- AraujoGEResendeCBCardosoACTeixeiraALKeefeRSSalgadoJVValidity and reliability of the Brazilian Portuguese version of the BACS (Brief Assessment of Cognition in Schizophrenia)Clinics (Sao Paulo)201570427828226017795
- American Psychiatric AssociationDiagnostic and Statistical Manual of Mental disorders (DSM-IV-TR)Washington, DCAmerican Psychiatric Association2000
- SheehanDVLecrubierYSheehanKHThe Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10J Clin Psychiatry199859Suppl 202233 quiz 34–57
- HochbergerWCHillSKNelsonCLUnitary construct of generalized cognitive ability underlying BACS performance across psychotic disorders and in their first-degree relativesSchizophr Res2016170115616126645510
- WHO Collaborating Centre for Drug Statistics MethodologyATC/DDD Index2016 Available from: http://www.whocc.no/atc_ddd_index/Accessed August 25, 2016
- PattersonTLGoldmanSMcKibbinCLHughsTJesteDVUCSD Performance-Based Skills Assessment: development of a new measure of everyday functioning for severely mentally ill adultsSchizophr Bull200127223524511354591
- MausbachBTHarveyPDGoldmanSRJesteDVPattersonTLDevelopment of a brief scale of everyday functioning in persons with serious mental illnessSchizophr Bull20073361364137217341468
- McIntoshBJZhangXYKostenTPerformance-based assessment of functional skills in severe mental illness: results of a large-scale study in ChinaJ Psychiatr Res20114581089109421300378
- KanedaAKatagaiTYasui-FurukoriNComparing the influences of age and disease on the Brief Assessment of Cognition in Schizophrenia in Japanese patients with schizophreniaNeuropsychiatr Dis Treat201391203120823983469
- NorburyCFSparksADifference or disorder? Cultural issues in understanding neurodevelopmental disordersDev Psychol2013491455822390668
- YoshidaTSugaMArimaKCriterion and construct validity of the CogState Schizophrenia Battery in Japanese patients with schizophreniaPLoS One201165e2046921637776
- KishiTMoriwakiMKawashimaKInvestigation of clinical factors influencing cognitive function in Japanese schizophreniaNeurosci Res201066434034420025912
- HoriHYoshimuraRKatsukiAThe cognitive profile of aripiprazole differs from that of other atypical antipsychotics in schizophrenia patientsJ Psychiatr Res201246675776122464338
- LinCHHuangCLChangYCClinical symptoms, mainly negative symptoms, mediate the influence of neurocognition and social cognition on functional outcome of schizophreniaSchizophr Res20131461–323123723478155